Mahamaya Lifesciences IPO Subscription
The Mahamaya Lifesciences IPO subscription reflects the demand received from different investor categories during the bidding period. The subscription data includes the number of shares offered, shares bid for, and the subscription multiple (X) for categories such as Qualified Institutional Buyers (QIBs), Non-Institutional Investors (NIIs), and Retail Individual Investors (RIIs).
As per the latest subscription update, the Mahamaya Lifesciences IPO has received bids for 70,23,600 shares against 41,17,200 shares offered, resulting in an overall subscription of 1.71x. the NII category is subscribed 3.99x, Retail Investors 1.02x, and QIBs 1.19x.
- Retail
- 1.02x
- NII
- 3.99x
- QIB
- 1.19x
- Total
- 1.71x
Current GMP
₹0 (0.00%)
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
Mahamaya Lifesciences IPO Subscription Details ( Thu, 13 Nov 25 01:52 PM)
| Category | Shares Offered | Shares Bid For | Subscription (x) |
|---|---|---|---|
| Qualified Institutions | 1,176,000 | 1,401,600 | 1.19x |
| Non-Institutional | 882,000 | 3,514,800 | 3.99x |
| Retail Investors | 2,059,200 | 2,107,200 | 1.02x |
| Total | 4,117,200 | 7,023,600 | 1.71x |
Subscription figures are updated periodically and may change until issue closing. Data reflects bids placed across exchanges.
Application Wise Breakup (Approximate)
| Category | Reserved Apps | Applied Apps | Times (x) |
|---|---|---|---|
| Non-Institutional | - | 146 | - |
| Retail Investors | - | 878 | - |
Subscription figures are updated periodically and may change until issue closing. Data reflects bids placed across exchanges.
Shares bids Against Offered
Disclaimer: This data is for informational purposes only and does not constitute investment advice.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
Where Can I Check the Mahamaya Lifesciences IPO Live Subscription Status?
You can check the Mahamaya Lifesciences IPO live subscription status on the IPO Master App or the official websites of the BSE. The live subscription data is updated regularly during the IPO bidding period and displays category-wise subscription figures for Retail Individual Investors (RII), Non-Institutional Investors (NII), Qualified Institutional Buyers (QIB), Employees (if applicable), and the overall IPO subscription.
What is Mahamaya Lifesciences IPO retail subscription status?
The Retail Individual Investor (RII) portion of the Mahamaya Lifesciences IPO was subscribed 1.02 times as of Thu, Nov 13, 2025 07:22 PM. The public issue closed on Thu, Nov 13, 2025 for bidding.
How to subscribe Mahamaya Lifesciences IPO?
Investors can apply for the Mahamaya Lifesciences IPO online through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or via UPI using a SEBI-registered stockbroker or trading app. Select the desired lot size, enter your bid within the price band, and submit your application during the IPO subscription period. The application amount remains blocked in your bank account until the IPO allotment process is completed.
How many times Mahamaya Lifesciences IPO subscribed?
The Mahamaya Lifesciences IPO was subscribed 1.71x times at the close of bidding period on Thu, Nov 13, 2025.
How to check Mahamaya Lifesciences IPO allotment?
The Mahamaya Lifesciences IPO allotment was finalized on Fri, Nov 14, 2025. You can check the Mahamaya Lifesciences IPO allotment status on the registrar's website or the BSE/NSE websites using your PAN, application number, or DP/Client ID. You can also check the allotment status quickly through the IPO Master App.
When Will the Mahamaya Lifesciences IPO Be Listed?
The Mahamaya Lifesciences IPO was listed on Tue, Nov 18, 2025, on the BSE.
What is the Mahamaya Lifesciences IPO Qualified Institutional Buyers (QIB) subscription status?
The Qualified Institutional Buyers (QIB) category of Mahamaya Lifesciences IPO was subscribed 1.19 times as of Thu, Nov 13, 2025 07:22 PM.